CIK 0001356576 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2022 | FY2021 | |
|---|---|---|---|---|
| Revenue (USD) | 719.0 M | 667.2 M | ||
| Net income (USD) | 127.0 M | 113.1 M | ||
| Diluted EPS (USD/shares) | -0.68 | 1.04 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-19 | 8-K | 8-K items 2.02 | 2026-10-19 |
| 2026-10-15 | 8-K | 8-K items 5.07,9.01 | 2026-10-15 |
| 2026-10-06 | 425 | 425 | |
| 2026-10-06 | DEFA14A | DEFA14A | |
| 2026-09-11 | DEFM14A | DEFM14A | |
| 2026-08-14 | 4 | FORM 4 | 2026-08-12 |
| 2026-08-14 | 4 | FORM 4 | 2026-08-12 |
| 2026-08-14 | 4 | FORM 4 | 2026-08-12 |
| 2026-08-14 | 4 | FORM 4 | 2026-08-12 |
| 2026-08-14 | 4 | FORM 4 | 2026-08-12 |
| 2026-08-06 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-04 | 425 | 425 | |
| 2026-08-03 | 425 | 425 | |
| 2026-08-03 | DEFA14A | DEFA14A | |
| 2026-08-03 | 425 | 425 | |
| 2026-08-03 | 8-K | FORM 8-K items 8.01,9.01 | 2026-08-03 |
| 2026-08-03 | DEFA14A | DEFA14A | |
| 2026-08-03 | 425 | 425 | |
| 2026-08-03 | 8-K | FORM 8-K items 8.01,9.01 | 2026-08-03 |
| 2026-08-03 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-03 | 8-K | 8-K items 2.02,9.01 | 2026-08-03 |
| 2026-08-03 | DEFA14A | DEFA14A | |
| 2026-08-03 | 425 | 425 | |
| 2026-08-03 | 8-K | FORM 8-K items 1.01,5.02,8.01,9.01 | 2026-08-01 |
| 2026-07-31 | 4 | FORM 4 | 2026-07-29 |
Forms on file (last 1,000): 4 446, 8-K 266, 144 67, 10-Q 37, SC 13G/A 27, DEFA14A 13, 4/A 13, DEF 14A 12. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=SUPN (0.002 USD), /gw/filings/filings?ticker=SUPN&form=8-K, /gw/filings/facts?ticker=SUPN&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange